Literature DB >> 18488259

Pulmonary Mycobacterium simiae infection: comparison with pulmonary tuberculosis.

C Maoz1, D Shitrit, Z Samra, N Peled, L Kaufman, M R Kramer, J Bishara.   

Abstract

To identify the clinical and radiological features distinguishing Mycobacterium simiae respiratory infection from pulmonary tuberculosis, the demographics, underlying conditions, and clinical and radiological findings of 121 consecutive patients with pulmonary tuberculosis and 102 with M. simiae respiratory infection were compared retrospectively. In the M. simiae group, the patients were older (mean age 69 +/- 16 years vs. 47 +/- 21 years, p = 0.0001), with a female predominance (62% vs. 45%, p = 0.008). Only 4% were of Ethiopian origin compared to 25% of the tuberculosis group (p = 0.0001). M. simiae infection was associated with significantly higher rates of smoking history, underlying chronic obstructive pulmonary disease, zero human immunodeficiency virus (HIV) infection compared to 10% in the tuberculosis group (p = 0.001), blunted symptoms, and noncavitary infiltrates in the lower/middle lobes on chest X-ray. HIV-negative patients with M. simiae respiratory infection are distinguishable from patients with pulmonary tuberculosis by several demographic, clinical, and radiological features. These findings have important diagnostic and therapeutic implications.

Entities:  

Mesh:

Year:  2008        PMID: 18488259     DOI: 10.1007/s10096-008-0522-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Authors:  Henry M Blumberg; William J Burman; Richard E Chaisson; Charles L Daley; Sue C Etkind; Lloyd N Friedman; Paula Fujiwara; Malgosia Grzemska; Philip C Hopewell; Michael D Iseman; Robert M Jasmer; Venkatarama Koppaka; Richard I Menzies; Richard J O'Brien; Randall R Reves; Lee B Reichman; Patricia M Simone; Jeffrey R Starke; Andrew A Vernon
Journal:  Am J Respir Crit Care Med       Date:  2003-02-15       Impact factor: 21.405

Review 2.  Disseminated Mycobacterium simiae infection in patients with AIDS.

Authors:  H M Al-Abdely; S G Revankar; J R Graybill
Journal:  J Infect       Date:  2000-09       Impact factor: 6.072

Review 3.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

4.  Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients.

Authors:  A Barzilai; B Rubinovich; D Blank-Porat; E Rubinstein; N Keller; I Levi
Journal:  Scand J Infect Dis       Date:  1998

5.  Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.

Authors:  S A Evans; A Colville; A J Evans; A J Crisp; I D Johnston
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

6.  Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.

Authors:  G Valero; F Moreno; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients.

Authors:  D E Griffith; W M Girard; R J Wallace
Journal:  Am Rev Respir Dis       Date:  1993-05

8.  Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study.

Authors:  David E Griffith; Barbara A Brown-Elliott; Richard J Wallace
Journal:  Clin Infect Dis       Date:  2003-10-01       Impact factor: 9.079

9.  Mycobacterium simiae infection in Israeli patients with AIDS.

Authors:  D Huminer; S Dux; Z Samra; L Kaufman; A Lavy; C S Block; S D Pitlik
Journal:  Clin Infect Dis       Date:  1993-09       Impact factor: 9.079

10.  Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review.

Authors:  G Valero; J Peters; J H Jorgensen; J R Graybill
Journal:  Am J Respir Crit Care Med       Date:  1995-11       Impact factor: 21.405

View more
  10 in total

Review 1.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

2.  Characterization of Clinical Isolates of Mycobacterium simiae Using Drug Susceptibility Tests and Molecular Analyses.

Authors:  Hoda Dezhkhi; Parissa Farnia; Azam Haddadi; Poopak Farnia; Ali Akbar Velayati
Journal:  Curr Microbiol       Date:  2021-04-13       Impact factor: 2.188

3.  Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium simiae: The First Reported Case in South Korea.

Authors:  Suk Hyeon Jeong; Su-Young Kim; Hyun Lee; Jun Soo Ham; Keum Bit Hwang; Subin Hwang; Sun Hye Shin; Myung Jin Chung; Seung Heon Lee; Sung Jae Shin; Won-Jung Koh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-10-01

4.  Computed Tomography Findings of Pulmonary Mycobacterium simiae Infection.

Authors:  Ayeh Baghizadeh; Payam Mehrian; Poopak Farnia
Journal:  Can Respir J       Date:  2017-01-03       Impact factor: 2.409

Review 5.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

6.  Evaluating the clinical significance of nontuberculous mycobacteria isolated from respiratory samples in Iran: an often overlooked disease.

Authors:  Zahra Mortazavi; Ahmadreza Bahrmand; Fatemeh Sakhaee; Reza Hosseini Doust; Farzam Vaziri; Seyed Davar Siadat; Abolfazl Fateh
Journal:  Infect Drug Resist       Date:  2019-07-03       Impact factor: 4.003

7.  Mycobacterium simiae: Harmless colonizer or deadly pathogen?

Authors:  Jean-Francois Jabbour; Amal Hamieh; Sima L Sharara; Souha S Kanj
Journal:  PLoS Pathog       Date:  2020-04-30       Impact factor: 6.823

8.  Emergence of Mycobacterium simiae: A retrospective study from a tertiary care center in Lebanon.

Authors:  Amal Hamieh; Ralph Tayyar; Houssam Tabaja; Saeed E L Zein; Pierre Bou Khalil; Nathalie Kara; Zeina A Kanafani; Nadim Kanj; Imad Bou Akl; George Araj; Ghina Berjaoui; Souha S Kanj
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

9.  Mycobacterium simiae pulmonary disease in Iran: systematic review and meta-analysis.

Authors:  M J Nasiri; M Heidary; T Azimi; H Goudarzi; P Tabarsi; D D Sarokhalil; M M Feizabadi
Journal:  New Microbes New Infect       Date:  2018-09-22

10.  Disseminated Mycobacterium simiae infection in a patient with adult-onset immunodeficiency due to anti-interferon-gamma antibodies - a case report.

Authors:  B S D P Keragala; C N Gunasekera; P D Yesudian; Chandima Guruge; B S Dissanayaka; D P Liyanagama; G I M Jinadasa; S R Constantine; H M M T B Herath
Journal:  BMC Infect Dis       Date:  2020-04-01       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.